Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

All News Activism M&A Podcasts Private Cos. Private Equity Restructuring Scoops & Exclusives SPACs

Page 78

M&A

FTC to Closely Examine Pfizer, Mylan Deal

By David Hatch
|
Published: October 29th, 2019
The transaction faces other regulatory hurdles, including a review by China, possible Brexit complications and clearances in nearly two dozen jurisdictions.
 Company
Solutions
Contact The Deal
Tel:
1-888-667-3325
International:
+1-212-224-3069
Email:
[email protected]
© 2024 The Deal.

Part of the Delinian Group. Terms of Use, Commercial Terms & Conditions, Privacy Policy, Accessibility, Modern Slavery Act